Roberto Burioni Selected Research

Roberto Burioni Research Topics

Disease

24	Infections 01/2020 - 11/2002
8	Human Influenza (Influenza) 05/2015 - 07/2003
3	Multiple Sclerosis 08/2020 - 08/2014
3	Progressive Multifocal Leukoencephalopathy 01/2016 - 01/2012
3	Virus Diseases (Viral Diseases) 08/2008 - 07/2003
2	Atherosclerosis 01/2016 - 01/2012
2	Atherosclerotic Plaque (Atheroma) 01/2012 - 08/2009
2	Cryoglobulinemia 01/2012 - 06/2008
2	Persistent Infection 06/2010 - 10/2006
2	Vesicular Stomatitis 10/2004 - 11/2002
1	COVID-19 08/2020
1	Necrosis 03/2016
1	Inflammation (Inflammations) 01/2016
1	Metabolic Diseases (Metabolic Disease) 01/2016
1	Mycoses (Diseases, Fungus) 01/2015
1	Schistosomiasis haematobia (Schistosomiasis haematobium) 09/2014
1	Demyelinating Diseases (Demyelinating Disease) 08/2014
1	Parasitic Diseases (Parasitic Disease) 02/2014
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 03/2013
1	Scrapie 03/2013
1	Animal Diseases 03/2013
1	Arbovirus Infections 01/2013
1	Communicable Diseases (Infectious Diseases) 01/2013
1	Necrotizing Enterocolitis 10/2012
1	Acute Coronary Syndrome 01/2012
1	Keratitis 09/2005
1	Reinfection 11/2002

Drug/Important Bio-Agent (IBA)

11	Monoclonal AntibodiesIBA 05/2015 - 07/2003
6	Antiviral Agents (Antivirals)IBA 08/2020 - 11/2002
6	VaccinesIBA 01/2017 - 10/2004
6	AntibodiesIBA 05/2015 - 11/2002
5	Proteins (Proteins, Gene)FDA Link 03/2013 - 10/2006
4	Neutralizing AntibodiesIBA 01/2019 - 10/2006
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 09/2005
4	EpitopesIBA 05/2015 - 10/2006
3	AntigensIBA 03/2016 - 06/2008
3	Natalizumab (Tysabri)FDA Link 01/2016 - 01/2012
3	Formaldehyde (Formol)FDA Link 04/2015 - 02/2014
3	Immunoglobulin Fab FragmentsIBA 03/2010 - 07/2003
3	Glycoproteins (Glycoprotein)IBA 12/2009 - 11/2002
2	InterferonsIBA 08/2020 - 03/2016
2	Pharmaceutical PreparationsIBA 08/2020 - 10/2009
2	Ether (Diethyl Ether)IBA 09/2014 - 02/2014
2	Broadly Neutralizing AntibodiesIBA 08/2008 - 01/2008
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	NucleosidesIBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2017
1	Interleukin-2 (IL2)IBA 03/2016
1	CytokinesIBA 03/2016
1	Apolipoproteins E (ApoE)IBA 01/2016
1	Immunomodulating AgentsIBA 08/2014
1	Raltegravir Potassium FDA Link 11/2013
1	dolutegravirIBA 11/2013
1	Prion ProteinsIBA 03/2013
1	RNA (Ribonucleic Acid)IBA 03/2013
1	PrionsIBA 03/2013
1	Protein Isoforms (Isoforms)IBA 03/2013
1	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2012
1	Fungal DNAIBA 10/2012
1	Immunoglobulins (Immunoglobulin)IBA 01/2012
1	transgelinIBA 01/2012
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 10/2011
1	Hemagglutinins (Hemagglutinin)IBA 01/2011
1	CryoglobulinsIBA 06/2008
1	Immunoglobulin M (IgM)IBA 06/2008
1	Ribavirin (Virazole)FDA LinkGeneric 10/2006
1	Interferon-alpha (Interferon Alfa)IBA 10/2006
1	Immunoglobulin FragmentsIBA 11/2002

Therapy/Procedure

5	Therapeutics 04/2016 - 10/2006
1	Phage Therapy 01/2017
1	Immunotherapy 11/2012